Yeast fiber may boost cancer immunotherapy in melanoma patients
NCT ID NCT04513028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether beta-glucan, a natural fiber from yeast, can improve the immune response to the immunotherapy drug pembrolizumab in people with stage III or IV melanoma. Researchers will measure changes in immune cells from blood samples. The goal is to understand how beta-glucan affects the immune system, not to directly treat the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Louisville
RECRUITINGLouisville, Kentucky, 40202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can interferon keep melanoma from coming back after surgery?
- Pee power: urine bacteria may predict melanoma treatment success
- Could an immune-boosting pill make melanoma treatments work better?
- Could a Low-Protein diet boost immunotherapy for melanoma?
- New Pill-and-Immunotherapy combo aims to shrink melanoma before surgery
- Experimental virus therapy takes on advanced cancers in first human trial